AAK1 and nervous system disorder: Compound 7745 is an imidazo[1,2-b]pyridazine-based molecule originally developed to modulate AAK1 activity as a potential treatment of neurological disorders (Kd = 1 nM; 50% inhibitory concentration, <10 nM) (Fig. 6F) (39, 60).